Evidence map›Paper›PMID 33767785›Full record

ArticleJournal of medicine and life

Pediatric biobanks and parents of disabled children associations opinions on establishing children repositories in developing countries.

Svetlana Mykolaivna Gramatiuk, Irina Yuriivna Bagmut, Michael Ivanivich Sheremet, Karine Sargsyan, Alla Mironovna Yushko, Serhii Mykolaevich Filipchenko, Vitaliy Vasilyevich Maksymyuk, Volodimir Volodimirovich Tarabanchuk, Petro Vasilyevich Moroz, Andriy Ivanovich Popovich

Open access · diamondAbstract read
In one paragraph

Article in Journal of medicine and life. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Svetlana Mykolaivna GramatiukUkraine Association of Biobank, Institute of Cellular Biorehabilitation, Kharkiv, Ukraine.
Irina Yuriivna BagmutKharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine.
Michael Ivanivich SheremetSurgical department No.1, Bukovinian State Medical University, Chernivtsi Ukraine.
Karine SargsyanBiobank Graz, Medical University of Graz, Graz, Austria.
Alla Mironovna YushkoUkraine Association of Biobank, Institute of Cellular Biorehabilitation, Kharkiv, Ukraine.
Serhii Mykolaevich FilipchenkoKharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine.
Vitaliy Vasilyevich MaksymyukSurgical department No.1, Bukovinian State Medical University, Chernivtsi Ukraine.
Volodimir Volodimirovich TarabanchukSurgical department No.1, Bukovinian State Medical University, Chernivtsi Ukraine.
Petro Vasilyevich MorozSurgical department No.1, Bukovinian State Medical University, Chernivtsi Ukraine.
Andriy Ivanovich PopovichDepartment of Pathology (Pathology and Forensic Medicine), Bukovinian State Medical University, Chernivtsi, Ukraine.
Bukovinian State Medical University · UAKharkiv Medical Academy of Postgraduate Education · UAMedical University of Graz · ATYaroslav Mudryi National Law University · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pediatric biobanks are an indispensable resource for the research needed to bring advances in personalized medicine into pediatric medical care. It is unclear how or when these advances in medical care may reach children, but it is unlikely that research in adults will be adequate. We conducted the screening for a hypothetic problem in various European and American pediatric biobanks based on online surveys through e-mail distribution based on the Biobank Economic Modeling Tool (BEMT) questionnaire model. Participants in the survey had work experience in biobanking for at least 3 years or more. Contact information about the survey participants was confirmed on the social networks profiles (LinkedIn), as well as on generally available websites. First, we tried creating a model which can show the pediatric preclinical and basic clinical phase relationship and demonstrate how pediatric biobanking is linked to this process. Furthermore, we tried to look for new trends, and the final goal is to put the acquired knowledge into practice, so medical experts and patients could gain usable benefit from it. We concluded that leading positions must take into account ethical and legal aspects when considering the decision to include children in the biobank collection. However, communication with parents and children is essential. The biobank characteristics influence the biobank's motives to include children in the consent procedure. Moreover, the motives to include children influence how the children are involved in the consent procedure and the extent to which children are able to make voluntary decisions as part of the consent procedure.

Indexed as

Biological Specimen BanksChildren with DisabilitiesDeveloping CountriesParentsChildCommunicationHumansRisk ManagementSurveys and Questionnairesethical and legal aspectspediatric biobankingspecimens of sick children

Identifiers

PMID33767785
PMCPMC7982269
OpenAlexW3137868831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.